Ultimate magazine theme for WordPress.

Tyra Biosciences increased IPO on the high end of the calls> TYRA

By Colin Kellaher

Tyra Biosciences Inc. said its increased IPO of 10.8 million shares at $ 16 apiece was at the top of the expected range of $ 14-16.

The precision oncology company of Carlsbad, California, which had already increased its offering from 6.7 million to 9 million shares, expected gross proceeds of $ 172.8 million.

Tyra said it has also given the syndicate banks a 30-day option to purchase up to an additional 1.62 million shares.

Tyra stock is scheduled to trade under the symbol TYRA on Wednesday.

Write to Colin Kellaher at [email protected]

Comments are closed.